Divisional CEO
at Ncardia
Dr. Jeroen de Groot is a highly accomplished R&D and business executive who has an extensive background in leading international contract research organizations, with particular experience in innovation, drug discovery and development. Groot was previously chief operations officer early discovery at Charles River Laboratories, where he spent almost a decade. He also worked at the biotech company Galapagos and, prior to that, spent 13 years at TNO, where he began his career as a bench scientist and was involved in research into bone and joint diseases, inflammatory and degenerative diseases, ADME, pharmacokinetics and human studies. He studied biology at Leiden University and earned a PhD at Utrecht University Medical Center and TNO.
Education
Accreditations
Member recognised by the American College of Rheumatology
Member recognised by the Orthopaedic Research Society
Member recognised by the Osteoarthritis Research Society International
Member recognised by the Dutch Society for Rheumatology
Member recognised by the Dutch Institute for Biology
Areas of Expertise
Got a Question for Jeroen de Groot, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
